5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | BUY | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.78▼ | 2.79▼ | 2.78▲ | 2.93▼ | 2.68▲ |
MA10 | 2.78▼ | 2.78▲ | 2.81▼ | 2.75▲ | 2.77▲ |
MA20 | 2.79▼ | 2.82▼ | 2.90▼ | 2.70▲ | 2.81▼ |
MA50 | 2.79▼ | 2.95▼ | 2.84▼ | 2.82▼ | 2.36▲ |
MA100 | 2.92▼ | 2.81▼ | 2.71▲ | 2.76▲ | 2.87▼ |
MA200 | 2.88▼ | 2.70▲ | 2.65▲ | 2.54▲ | 8.59▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.003▲ | -0.022▼ | 0.047▲ | -0.054▼ |
RSI | 45.328▼ | 39.064▼ | 40.407▼ | 51.921▲ | 51.905▲ |
STOCH | 32.381 | 45.286 | 25.505 | 77.072 | 29.765 |
WILL %R | -85.714▼ | -69.697 | -81.481▼ | -41.898 | -63.758 |
CCI | 34.314 | 9.030 | -58.090 | 37.700 | -10.386 |
Saturday, September 13, 2025 04:00 PM
HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals (NASDAQ: NRXP), has completed its acquisition of Dura Medical, expanding its footprint in Florida with a focus on advanced ...
|
Tuesday, September 09, 2025 12:14 PM
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that its wholly owned subsidiary HOPE Therapeutics Inc. has closed the acquisition of Dura Medical, a ...
|
Tuesday, September 09, 2025 08:30 AM
Austin, Texas, United States, September 9th, 2025, FinanceWire NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
12/09/25 | 2.89 | 2.8967 | 2.73 | 2.80 | 485,984 |
11/09/25 | 2.97 | 3.03 | 2.8356 | 2.88 | 388,513 |
10/09/25 | 3.15 | 3.1894 | 2.95 | 2.97 | 421,236 |
09/09/25 | 2.85 | 3.17 | 2.81 | 3.15 | 1,046,488 |
08/09/25 | 2.88 | 3.00 | 2.79 | 2.84 | 850,341 |
05/09/25 | 2.65 | 2.75 | 2.57 | 2.75 | 172,993 |
04/09/25 | 2.66 | 2.66 | 2.53 | 2.63 | 191,731 |
03/09/25 | 2.66 | 2.805 | 2.5232 | 2.60 | 351,748 |
02/09/25 | 2.28 | 2.73 | 2.28 | 2.60 | 650,472 |
29/08/25 | 2.52 | 2.535 | 2.26 | 2.32 | 571,893 |
|
|
||||
|
|
||||
|
|